Aarti Drugs Limited has informed the Exchange about Schedule of meet
AARTIDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Drugs Limited has informed the stock exchanges about its participation in an investor conference scheduled for 21st August 2025, from 10:00 am to 2:00 pm in BKC, Mumbai. The meeting is organized by Systematix and will involve one-on-one and group meetings with analysts and institutional investors. The company has clarified that discussions will be based solely on publicly available information, with no unpublished price sensitive information (UPSI) intended to be shared. This is a routine compliance filing under SEBI's Listing Obligations and Disclosure Requirements (Regulation 30).
This is a standard regulatory disclosure with no material business impact. It signals normal investor outreach activity and reflects the company's engagement with the analyst community, but should not move the stock price on its own.